Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Yiling Biotechnology is a small private healthcare company in Changsha, Hunan, China, focused on the distribution and sale of medical devices, medical consumables, and related healthcare products. Public business-registration records indicate that it is licensed for Class III medical device operations and drug wholesale, while also engaging in Class I and II medical device sales and leasing, software and IT services, equipment maintenance, and supply-chain related activities. The company appears to operate primarily as a commercial healthcare products distributor rather than as a drug discovery or therapeutic-development biotech. No credible public evidence was found of a proprietary drug pipeline, named therapeutic programs, or a distinct R&D platform. For a biotech analyst, this entity is best understood as a small active healthcare commerce and services company rather than an innovation-stage biopharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunan Yiling Biotechnology.